---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-012450"
form_type: "8-K"
ticker: null
cik: "0001825962"
company_name: "Quadro Acquisition One Corp."
filed_at: "2023-02-16T23:59:59+00:00"
generated_at: "2026-06-19T09:43:15.439535+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Kismet Acquisition Two receives Nasdaq deficiency notice for audit committee composition

## Summary
- Received deficiency notice on Feb 13, 2023 due to director Verdi Israelyan's resignation on Sep 5, 2022.
- Audit committee now has two members; Nasdaq rule requires three.
- Cure period until earlier of next annual meeting or Sep 5, 2023 (or Mar 6, 2023 if meeting before then).
- Company expects to regain compliance before the cure period expires.

## SEC filing metadata
- accession: 0001213900-23-012450
- form_type: 8-K
- cik: 0001825962
- company_name: Quadro Acquisition One Corp.
- filed_at: 2023-02-16T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1825962/000121390023012450/0001213900-23-012450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1825962/000121390023012450/ea173804-8k_kismetacq2.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-012450
- JSON: https://secwatch.observer/filing/0001213900-23-012450.json
- Plain text: https://secwatch.observer/filing/0001213900-23-012450.txt

## Key facts
- Listing & Compliance Notices
  Quadro Acquisition One Corp. received a nasdaq deficiency notice notice regarding audit committee (rules 5605, 5605(c)(4)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: audit committee
  - Rules: 5605, 5605(c)(4)
  source text: February 13, 2023, Kismet Acquisition Two Corp., a Cayman Islands exempted company (the “Company”), received a deficiency notice from the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, as a result of the resignation of Verdi Israelyan from the board of directors of the Company (the “Board”) and the audit committee of the Board (“Audit Committee”) on September 5, 2022, the Company is no longer in compliance with the continued listing requirements set forth in Nasdaq Listing Rule 5605 regarding the composition of the Audit Committee, because the Audit Committee is now comprised of on
  evidence_url: https://www.sec.gov/Archives/edgar/data/1825962/000121390023012450/0001213900-23-012450-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.